Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

ClinicalTrials.gov ID: NCT02648204

Public ClinicalTrials.gov record NCT02648204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 1:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes.

Study identification

NCT ID
NCT02648204
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,201 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 5, 2016
Primary completion
Apr 9, 2017
Completion
May 18, 2017
Last update posted
Oct 14, 2019

2016 – 2017

United States locations

U.S. sites
100
U.S. states
30
U.S. cities
88
Facility City State ZIP Site status
Novo Nordisk Investigational Site Tuscumbia Alabama 35674 —
Novo Nordisk Investigational Site Chandler Arizona 85224 —
Novo Nordisk Investigational Site Phoenix Arizona 85032 —
Novo Nordisk Investigational Site Phoenix Arizona 85050 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Buena Park California 90620 —
Novo Nordisk Investigational Site Carlsbad California 92008 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Huntington Park California 90255 —
Novo Nordisk Investigational Site Lincoln California 95648 —
Novo Nordisk Investigational Site Los Angeles California 90057 —
Novo Nordisk Investigational Site Montclair California 91763 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site Riverside California 92506 —
Novo Nordisk Investigational Site San Diego California 92103 —
Novo Nordisk Investigational Site Tustin California 92780 —
Novo Nordisk Investigational Site Van Nuys California 91405 —
Novo Nordisk Investigational Site Denver Colorado 80220 —
Novo Nordisk Investigational Site Norwalk Connecticut 06851 —
Novo Nordisk Investigational Site Clearwater Florida 33756 —
Novo Nordisk Investigational Site Clearwater Florida 33761 —
Novo Nordisk Investigational Site Coral Gables Florida 33134 —
Novo Nordisk Investigational Site Edgewater Florida 32132 —
Novo Nordisk Investigational Site Fort Lauderdale Florida 33316 —
Novo Nordisk Investigational Site Kissimmee Florida 34741 —
Novo Nordisk Investigational Site Miami Florida 33173 —
Novo Nordisk Investigational Site Orlando Florida 32804 —
Novo Nordisk Investigational Site Orlando Florida 32806 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33027 —
Novo Nordisk Investigational Site Port Orange Florida 32127 —
Novo Nordisk Investigational Site Tampa Florida 33614 —
Novo Nordisk Investigational Site Tampa Florida 33634 —
Novo Nordisk Investigational Site Adairsville Georgia 30103 —
Novo Nordisk Investigational Site Atlanta Georgia 30342 —
Novo Nordisk Investigational Site Bainbridge Georgia 39819 —
Novo Nordisk Investigational Site Conyers Georgia 30094-5965 —
Novo Nordisk Investigational Site Marietta Georgia 30060 —
Novo Nordisk Investigational Site Marietta Georgia 30067 —
Novo Nordisk Investigational Site Suwanee Georgia 30024 —
Novo Nordisk Investigational Site Meridian Idaho 83646 —
Novo Nordisk Investigational Site Addison Illinois 60101 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Gillespie Illinois 62033 —
Novo Nordisk Investigational Site Gurnee Illinois 60031 —
Novo Nordisk Investigational Site Peoria Illinois 61602 —
Novo Nordisk Investigational Site Avon Indiana 46123 —
Novo Nordisk Investigational Site Evansville Indiana 47714 —
Novo Nordisk Investigational Site Greenfield Indiana 46140 —
Novo Nordisk Investigational Site Indianapolis Indiana 46254 —
Novo Nordisk Investigational Site Muncie Indiana 47304 —
Novo Nordisk Investigational Site Newton Kansas 67114 —
Novo Nordisk Investigational Site Park City Kansas 67219 —
Novo Nordisk Investigational Site Covington Kentucky 41011 —
Novo Nordisk Investigational Site Louisville Kentucky 40213 —
Novo Nordisk Investigational Site Owensboro Kentucky 42303 —
Novo Nordisk Investigational Site Hyattsville Maryland 20782 —
Novo Nordisk Investigational Site Oxon Hill Maryland 20745 —
Novo Nordisk Investigational Site Methuen Massachusetts 01844 —
Novo Nordisk Investigational Site Rochester Michigan 48307 —
Novo Nordisk Investigational Site Port Gibson Mississippi 39150 —
Novo Nordisk Investigational Site Missoula Montana 59808 —
Novo Nordisk Investigational Site Trenton New Jersey 08611 —
Novo Nordisk Investigational Site New York New York 10016 —
Novo Nordisk Investigational Site Garner North Carolina 27529 —
Novo Nordisk Investigational Site Whiteville North Carolina 28472 —
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103 —
Novo Nordisk Investigational Site Cincinnati Ohio 45242 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Mason Ohio 45040-6815 —
Novo Nordisk Investigational Site Wadsworth Ohio 44281-9236 —
Novo Nordisk Investigational Site Tulsa Oklahoma 74136 —
Novo Nordisk Investigational Site Corvallis Oregon 97330-3737 —
Novo Nordisk Investigational Site Fleetwood Pennsylvania 19522 —
Novo Nordisk Investigational Site Harleysville Pennsylvania 19438 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15224-2215 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15236 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Moncks Corner South Carolina 29461 —
Novo Nordisk Investigational Site Spartanburg South Carolina 29303 —
Novo Nordisk Investigational Site Rapid City South Dakota 57702 —
Novo Nordisk Investigational Site Humboldt Tennessee 38343 —
Novo Nordisk Investigational Site Arlington Texas 76015 —
Novo Nordisk Investigational Site Corpus Christi Texas 78404 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Houston Texas 77025 —
Novo Nordisk Investigational Site Houston Texas 77040 —
Novo Nordisk Investigational Site Houston Texas 77074 —
Novo Nordisk Investigational Site Houston Texas 77079 —
Novo Nordisk Investigational Site Houston Texas 77081 —
Novo Nordisk Investigational Site Houston Texas 77090 —
Novo Nordisk Investigational Site Katy Texas 77450 —
Novo Nordisk Investigational Site San Antonio Texas 78231 —
Novo Nordisk Investigational Site Sugar Land Texas 77479 —
Novo Nordisk Investigational Site Riverton Utah 84065 —
Novo Nordisk Investigational Site St. George Utah 84790 —
Novo Nordisk Investigational Site Spokane Washington 99216-1557 —
Novo Nordisk Investigational Site Walla Walla Washington 99362-4445 —
Novo Nordisk Investigational Site Wenatchee Washington 98801-2028 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02648204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2019 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02648204 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →